The role of glia in protein aggregation

Neurobiol Dis. 2020 Sep:143:105015. doi: 10.1016/j.nbd.2020.105015. Epub 2020 Jul 12.

Abstract

Protein aggregation diseases involve intracellular accumulation or extracellular deposition of certain protein species in neuronal or glial cells, leading to neurodegeneration and shortened lifespan. Prime examples include Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD), which are affected by overlapping or specific aggregation-prone proteins. Mounting evidence suggests that dysfunctional glial cells may be major drivers for some diseases, and when they are not causal factors, they could still significantly exacerbate or alleviate disease progression by playing a plethora of detrimental or beneficial roles. Here we review the diverse functions performed by glial cells in a variety of protein aggregation diseases, highlighting the complexity of the issue and the interconnected relationships between these multifaceted effects.

Keywords: Alzheimer's disease; Amyotrophic lateral sclerosis; Astrocytes; Aβ; Glia; Microglia; Oligodendrocytes; Parkinson's disease; Protein aggregation; α-Syn.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Neurodegenerative Diseases / pathology*
  • Neuroglia / pathology*
  • Protein Aggregates
  • Protein Aggregation, Pathological / pathology*

Substances

  • Protein Aggregates